Autosomal dominant dementia with widespread neurofibrillary tangles

Annals of Neurology

Volumn 42, Issue 4, 1997, Pages 564-572

  Reed, Lee A ^a,b   Grabowski, Thomas J ^b   Schmidt, Marie Luise ^c   Morris, John C ^d   Goate, Alison ^d   Solodkin, Ana ^b,e   Van Hoesen, Gary W ^b,e   Schelper, Robert L ^a   Talbot, Chris J ^d   Wragg, Michelle A ^d   Trojanowski, John Q ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; TAU PROTEIN;

ADULT; AGED; AMNESIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PAIRED HELICAL FILAMENT; PEDIGREE ANALYSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; UNITED STATES;

AGE OF ONSET; AGED; ANTIBODY SPECIFICITY; APOLIPOPROTEINS E; DEMENTIA; EPITOPES; FEMALE; GENES, DOMINANT; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIMBIC SYSTEM; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROPIL THREADS; ORGAN SIZE; PEDIGREE; PHENOTYPE; PRESENILIN-2; TAU PROTEINS;

EID: 0030826625     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420406     Document Type: Article

References (62)

1. Goedert M, Trojanowski JQ, Lee VM-Y. The neurofibrillary pathology of Alzheimer's disease. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological disease. 2nd ed. Newton, MA: Butterworth Heinemann, 1997:613-627
2. Trojanowski JQ, Clark CM, Schmidt ML, et al. Implications of tau-rich neurofibrillary lesions for the pathobiology and diagnosis of Alzheimer's disease. In: Appel S, ed. Current neurology, vol 16. Chicago: Mosby-Year Book, 1996:93-113
3. Feany MB, Dickson DW. Neurodegenerative disotders with extensive tau pathology: a comparative study and review. Ann Neurol 1996;40:139-148
4. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neutopathol Exp Neurol 1996;55:53-67
5. Yamamoto T, Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 1986;12: 3-9
6. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive neocortical network of PHFtau-rich dystrophic neurites permeates nearly all neuritic and diffuse plaques in Alzheimer disease. FEBS Lett 1994;344:69-73
7. 262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 1995;270:18917-18922
8. Mercken M, Vandermeeren M, Lübke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84:265-272
9. Biernat J, Mandelkow E-M, Schröter C, et al. The switch of tau protein to an Alzheimer-like state induces the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. Embo J 1992;11:1593-1597
10. Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at serine-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-5070
11. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-1099
12. Lang E, Otvos L. A serine→ proline change in the Alzheimer's disease-associated epitope Tau-2 results in altered secondary structure, but phosphorylation overcomes the conformational gap. Biochem Biophys Res Commun 1992;188:162-169
13. Ksiezak-Reding H, Chien C-H, Lee VM-Y, Yen S-H. Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res 1990;25:412-419
14. Hyman BT, Tanzi RE, Marzloff K, et al. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992; 51:76-83
15. Shaw G, Chau V. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain. Proc Natl Acad Sci USA 1988;85:2854-2858
16. Talbot C, Houlden H, Craddock N, et al. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 1996;7:534-536
17. Auer IA, Schmidt ML, Lee VM-Y, et al. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol 1995;90: 547-551
18. Kiuchi A, Otsuka N, Namba Y, et al. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol 1991;82:1-5
19. Mandybur TI, Nagpaul AS, Pappas Z, Niklowitz WJ. Alzheimer neurofibrillary change in subacute sclerosing panencephalitis. Ann Neurol 1977;1:103-107
20. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019
21. Hof PR, Nimchinsky EA, Buée-Scherrer V, et al. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol 1994;88:397-404
22. Oyanagi K, Makifuchi T, Ohtoh T, et al. Amyotrophic lateral sclerosis of Guam: the nature of the neuropathological findings. Acta Neuropathol 1994;88:405-412
23. Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles: a study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 1993;116:281-302
24. Geddes JF, Vowles GH, Robinson SFD, Sutcliffe JC. Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer. Neuropathol Appl Neurobiol 1996;22:12-16
25. Hilton DA, Love S, Ferguson I, Newman P. Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathol 1995;90:101-106
26. Kosaka K. Diffuse neurofibrillary tangles with calcification: a new presenile dementia. J Neurol Neurosurg Psychiatry 1994; 57:594-596
27. Masliah E, Hansen LA, Quijada S, et al. Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy. Ann Neurol 1991;29:389-396
28. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173
29. Globe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034
30. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008
31. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 1994;42:137-152
32. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105
33. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024
34. Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-770
35. Chin SS-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
36. Ohara S, Kondo K, Morita H, et al. Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous matriage. Neurology 1992;42:1009-1014
37. Brown J, Lantos P, Stratton M, et al. Familial progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1993;56:473-476
38. Tetrud JW, Golbe LI, Forno LS, Farmer PM. Autopsy proven progressive supranuclear palsy in two siblings. Neurology 1996; 6:931-934
39. de Yébenes JG, Satasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy: description of a pedigree and review of the literature. Brain 1995;118:1095-1103
40. Cruz-Sanchez FF, Rossi ML, Cardozo A, et al. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. Neurosci Lett 1992;136:43-46
41. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
42. Itoh Y, Yamada M, Yoshida R, et al. Dementia charactetized by abundant neurofibrillary tangles and scarce senile plaques: a quantitative pathological study. Eur Neurol 1996;36:94-97
43. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subset in very old subjects. Acta Neuropathol 1994;88:565-570
44. Ulrich J, Spillantini MG, Goedert M, et al. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1992;1:257-264
45. Ikeda K, Akiyama H, Arai T, et al. A subset of senile dementia with high incidence of the apolipoprotein E ε2 allele. Ann Neurol 1997;41:693-695
46. Martinoli MG, Trojanowski JQ, Schmidt ML, et al. Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol 1995;90:239-243
47. Tabaton M, Rolleri M, Masturzo P, et al. Apolipoprotein E ε4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995;45:1764-1765
48. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on ApoE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437
49. Sumi SM, Bird TD, Nochlin D, Raskind MA. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 1992;42:120-127
50. Spillantini MG, Crowther RA, Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 1996;92: 42-48
51. Brown J, Lantos PL, Roques P, et al. Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathologic study. J Neurol Sci 1996;135:21-30
52. Sima AAF, Defendini R, Keohane C, et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996;39: 734-743
53. Foster NL, Wilhelmsen K, Sima AAF, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997;41:706-715
54. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472-481
55. Higuchi Y, Iwaki T, Tateishi J. Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy. Neuropathol Appl Neurobiol 1995;21:246-254
56. Braak H, Jellinger K, Braak E, Bohl J. Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol 1992;84:478-483
57. Flament S, Delacourte A, Verny M, et al. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of Alzheimer's type. Acta Neuropathol 1991;81:591-596
58. Ksiezak-Reding H, Morgan K, Mattiace LA, et al. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994;145:1496-1508
59. Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;159-168
60. Feany MB, Ksiezak-Reding H, Liu W-K, et al. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 1995;90:37-43
61. Schmidt ML, Huang R, Martin JA, et al. Neurofibrillary tangles in progressive supranuclear palsy contain the same epitopes identified in Alzheimer's disease PHF-tau. J Neuropathol Exp Neurol 1996;55:534-539
62. Mawal-Dewan M, Schmidt ML, Balin B, et al. Identification of phosphorylated sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol 1996;55:1051-1059